Merck (MRK) Non-Current Debt (2009 - 2026)

Merck (MRK) has 18 years of Non-Current Debt data on file, last reported at $46.7 billion in Q1 2026.

• Non-Current Debt for Q1 2026 came in at $46.7 billion, up 39.39% year-over-year; the trailing twelve-month figure through Mar 2026 was $46.7 billion (up 39.39% YoY), and the FY2025 annual result was $46.8 billion, up 35.66% from the prior year.
• Non-Current Debt steadied at $46.7 billion in Q1 2026 per MRK's latest filing, from $46.8 billion in the prior quarter.
• Over five years, Non-Current Debt peaked at $46.8 billion in Q4 2025 and troughed at $28.1 billion in Q1 2023.
• A 5-year average of $34.3 billion and a median of $34.0 billion in 2025 frame the typical range for Non-Current Debt.
• The sharpest annual moves came in 2023 and 2026: Non-Current Debt fell 8.21% in 2023, then jumped 39.39% in 2026.
• A 5-year view of Non-Current Debt shows it stood at $28.7 billion in 2022, then advanced by 17.18% to $33.7 billion in 2023, then grew by 2.31% to $34.5 billion in 2024, then jumped by 35.66% to $46.8 billion in 2025, then dropped by 0.16% to $46.7 billion in 2026.
• Business Quant data shows MRK's Non-Current Debt at $46.7 billion in Q1 2026, $46.8 billion in Q4 2025, and $40.0 billion in Q3 2025.